Lexaria Bioscience Corp. (LEXX) › Gross ProfitLexaria Bioscience Corp. (LEXX) — Gross ProfitAnnual figures by fiscal year, from SEC filings.2010: $88.9K2011: $465.9K2012: $574.5K2013: $302.3K2014: $02015: -$15.2K2016: -$4.9K2017: $33.9K2018: $408.1K2019: $199.7K2020: $215.4K2021: $547.4K2022: $183.6K2023: $194.7K2024: $459.5K2025: $703.2K$703.2K2010Gross Profit (USD)2025Fiscal YearGross ProfitChange YoY2025$703.2K+53.1%2024$459.5K+136.0%2023$194.7K+6.1%2022$183.6K-66.5%2021$547.4K+154.1%2020$215.4K+7.9%2019$199.7K-51.1%2018$408.1K+1104.2%2017$33.9K+792.0%2016-$4.9K+67.7%2015-$15.2K—2014$0-100.0%2013$302.3K-47.4%2012$574.5K+23.3%2011$465.9K+424.3%2010$88.9K—Other metrics: RevenueCost of RevenueOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share